Austin · Pre-Seed–Series A · 10 people tracked
Also known as KDT VENTURES LLC
Investment thesis
KdT invests at the earliest stages in frontier science, viewing science as the underlying 'source code' of reality. The firm backs founders who commercialize breakthroughs across biology, chemistry, physics, and computation, enabled by modern instrumentation, simulation, and AI that allow reading, interpreting, and redesigning the deepest layers of the physical world. It focuses on platform companies capable of engineering matter, energy, and information in new ways, spanning from atoms to bits. KdT also emphasizes long-term, deep relationships with portfolio companies and partners under its 'Venture for Science' approach.
Source: firm website, verified Aug 25, 2026.
Team · 10 people
from the firm's website & public directories
Founder mafia
2 people who came through KdT Ventures went on to found or lead other companies.
What they invest in
from 42 of 52 portfolio companiesBiotech ×31AI & Machine Learning ×15Healthtech ×12Deep Tech ×11Digital Health ×8Medical Devices ×7New Materials ×5Cleantech ×4
HQs:United States×28Canada×1
Investments · 52 tracked
founders shown can be your intro pathBy year:2025 · 22024 · 42022 · 12021 · 32020 · 22019 · 113 dated
BiotechFarmington, US
Azim Munivar(Executive Officer, Director, Promoter)
BoardStella Robertson(Director)inTravis Whitfill(Executive Officer, Director, Promoter)in
Board seatCain McClary· per SEC Form D
Co-investorsBios Partners
Faeth Therapeutics is a clinical-stage oncology company developing therapies that inhibit multiple nodes of the PI3K/AKT/mTOR (PAM) pathway.
BiotechHealthtechAustin, US
Anand Parikh(Executive Officer, Director, Promoter)Oliver Maddocks(Executive Officer, Director)
BoardAlex Morgan(Director)inJayson Dallas(Director)Robert Gould(Director)Stephen Hahn(Director)
Co-investorsAble PartnersAtacama VenturesCota CapitalFuture VenturesiSelect FundS2G Investments+4 more
Debut applies AI and biotechnology to discover and formulate cosmetic ingredients and beauty products, decoding skin and hair at the genomic level to create novel actives.
AI & Machine LearningBiotechConsumerSan Diego, US
Joshua Britton(Founder)
Co-investorsGS FuturesMaterial ImpactBreakout VenturesSandbox IndustriesACVC PartnersBetter Ventures Central Llc+8 more
Solugen develops a biomanufacturing platform using fermentation and bioprocessing technology to produce specialty chemicals at scale.
Advanced ManufacturingBiotechCleantechClimate TechHealthtechHouston, US
Sean Hunt(Founder/CTO)inGaurab Chakrabarti(Founder)in
BoardSeth Bannon(Director)in
Co-investorsFifty YearsFounders FundLowercarbon CapitalY CombinatorBaillie GiffordGIC+22 more
Andes adds beneficial soil microorganisms alongside agricultural seeds such as corn, soybean, canola, and wheat to accelerate the conversion of atmospheric CO₂ into soil inorganic carbon for durable carbon removal.
AgTechCleantechClimate TechAlameda, US
Board seatPhil Grayeski· per SEC Form D
Co-investorsCavallo VenturesVoyager Partners
Checkerspot uses microalgae precision fermentation to produce specialized lipids and fats, including a bio-equivalent source of the sn-2 palmitate fat found in mother's milk, rare bioactive fatty acids, and tropical fat alternatives.
BiotechClimate TechFoodTechNew MaterialsAlameda, US
Scott Franklin(Executive Officer, Director)Charles Dimmler(Executive Officer, Director)John Krzywicki(CEO)Layla Ward(CFO)Casey Lippmeier(CTO)Leon Parker(SVP, Molecular Biology)
Board seatAndrew Cain McClaryCain McClary· per SEC Form D
Co-investorsBaruch Future VenturesBreakout VenturesCavallo VenturesBuilders VCRefactor Capital
Specialty enzyme solutions combined with continuous manufacturing.
Advanced ManufacturingCarlsbad, US
Joshua Britton(Executive Officer, Director)
BoardCain A. McClary(Director)in
Board seatCain McClary· per SEC Form D · $2.6M raise · filed Jan 2020
Co-investorsCavallo Ventures
Particella, Inc. (formerly DNAlite Therapeutics) is a preclinical biotechnology company developing an oral lipid nanoparticle platform to deliver nucleic acids, such as mRNA, to the intestinal epithelium.
BiotechDeep TechSan Francisco, US
Mubhij Ahmad(Executive Officer, Director)David Rabuka(Director)Timothy Paul Day(Director)
BoardDrew Lanza(Director)
Board seatAndrew Cain McClary· per SEC Form D · $8.9M raise · filed Apr 2022
Co-investorsBerkeley CatalystBlue Bear Ventures
Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.
BiotechDeep TechSan Carlos, US
Matthew Hill(Executive Officer, Director)in
BoardPeter Zhou(Director)inJonathan Sheena(Director)
Board seatCain McClary· per SEC Form D
Co-investorsACVC PartnersAndreessen HorowitzRaptor GroupTriatomic CapitalAME Cloud VenturesDigitalis Ventures+1 more
Transcera is a biotech company developing a new class of therapeutics that use lipid trafficking pathways to direct extracellular proteins into lysosomes for degradation, aimed at treating chronic diseases.
BiotechDeep TechBoston, US
Wayne Lencer(Co-Founder & SAB Chair)Hunter Goble(Co-Founder & CEO)Justin Wolfe(Co-Founder & CSO)
Board seatPhil Grayeski· per SEC Form D · $1M raise · filed Jul 2021
Co-investorsPortal InnovationsTau Ventures
STRM.BIO develops a gene therapy delivery platform based on megakaryocyte-derived extracellular vesicles (STRM MVs) that target and deliver genetic cargoes preferentially to bone marrow and hematopoietic stem cells.
BiotechDeep TechMedical Devices
Co-investorsAscension VenturesBreakout LabsBreakout VenturesDelos CapitalNYBC Ventures
Abridge builds AI software that converts clinical conversations into structured insights for healthcare providers.
AI & Machine LearningDigital HealthHealthtechPhiladelphia, US
Shiv Rao(Founder & CEO)Shiv (Shivdev) Rao(Founder)inJulia Chapin(Executive Officer)Sagar Sanghvi(Executive Officer)
BoardAndy Weissman(Director)inSebastian Duesterhoeft(Director)in
Co-investorsAlpha Square Groupalphabet angelsAndreessen HorowitzBessemer Venture PartnersCapitalGCatalio Capital Management, LP+20 more
Aperiam Bio uses computer-vision algorithms to identify "hyperfolding" protein variants with improved expression, solubility, and stability, aiming for order-of-magnitude gains in protein performance.
AI & Machine LearningBiotechDeep TechAustin, US
Austin Cole(CEO & Founder)Guillaume Cottarel(Head of Program)Russell Durrett(Chief Business Officer)
Co-investorsCivilization Ventures Management, LlcOMX VenturesAxial VC
Braid Health combines AI imaging copilots with board-certified radiologists to provide second opinions on MRI, CT, and ultrasound scans, along with AI-generated explanations and workflow tools.
AI & Machine LearningDigital HealthHealthtech
Kevin Quennesson(Founder)in
Co-investorsBronze InvestmentsJazzya InvestmentsLux CapitalMyelin VC
Canaery (now General Sense) is developing scent-detection technology aimed at extending capabilities beyond the limits of human olfactory perception.
Deep TechHardware
Co-investors15th RockGood News VenturesBreakout VenturesDolby Family Ventures
Character Bio is a precision medicine company that integrates genomics, longitudinal clinical data, imaging, and AI-based biomarker analysis to identify genetic drivers of progressive polygenic eye diseases such as age-related macular degeneration and glaucoma.
AI & Machine LearningBiotechDigital HealthJersey City, US
Cheng Zhang(Executive Officer, Director)
BoardVivek Garipalli(Director)Nick Olsen(Director)Peter DiLaura(Director)
Co-investorsaMoonCantos VenturesCatalio Capital Management, LPDuke Capital PartnersLifeforce CapitalSanofi Ventures+3 more
Creasallis develops CreaTap, a patented "plug-and-play" antibody modification technology that improves the penetration of antibody-based drugs into solid tumours, applicable to monoclonal, bispecific, and antibody-drug conjugates.
Biotech
Zahra Jawad(Founder)
Co-investorsBlueYard CapitalPace VenturesZAKA VC
Co-investorsBetter Ventures Central LlcBlue Bear VenturesSafar Partners
Dimension Bio is a biotechnology company that designs and manufactures regenerative therapeutics using its BioNidum™ platform to restore tissue function lost to disease, trauma, or aging.
BiotechHealthtechNew MaterialsChicago, US
Caralynn Nowinski Collens, M.D.(Co-founder & CEO)Ramille Shah, Ph.D.(Co-founder & CSO)Ramille Shah(Director)Caralynn Collens(Executive Officer, Director)
BoardRima Chakrabarti(Director)in
Co-investorsBetter Ventures Central LlcLofty VenturesPathway BioventuresPortal InnovationsSolas BioVentures
Dyno Therapeutics develops artificial intelligence-powered genetic technologies for gene therapy, specifically engineering adeno-associated virus (AAV) capsids to improve gene delivery for treating genetic diseases.
AI & Machine LearningBiotechWatertown, US
Eric Kelsic(CEO & Cofounder)inSam Sinai(Vice President, Head of ML & Cofounder)inAdrian Veres(Chief Scientific Officer & Cofounder)George Church(Scientific Cofounder)Tomas Bjorklund(Scientific Co-founder)Alan Crane(Executive Chairman & Cofounder, Polaris Entrepreneur Partner)
Co-investorsAndreessen HorowitzCRV (Charles River Ventures)GENERAL INCEPTIONGV (Google Ventures)Lux CapitalObvious Ventures+2 more
Co-investorsHealthtech Capital
Co-investorsDCVC (Data Collective)
Epana Bio develops therapies for autoimmune diseases by leveraging genomics and AI to identify and target cellular origins of disease, with a focus on precision medicine for patient populations.
AI & Machine LearningBiotechDigital Health
Co-investorsBreakout LabsBreakout VenturesHAWKTAILHummingbird VenturesOMX VenturesRefactor Capital
Equii makes food products that combine complete protein with carbohydrates while reducing sugar, positioned around balanced nutrition.
ConsumerFoodTechWellness & Fitness
Monica Bhatia(Founder)in
Co-investorsAurum Venture PartnersVU Venture PartnersWestern Technology Investment
Index Biosystems builds an AI platform for food safety and quality assurance (FSQA) teams in food manufacturing, combining AI agents that automate investigations and audit prep with BioTags — food-grade, DNA-labeled microbial tracers that generate molecular data for tracing material movement and validating sanitation.
AI & Machine LearningBiotechFoodTechToronto, CA
Mike BorgDavid Singerin
Co-investorsUndeterred CapitalVanedge CapitalVanedge Capital Limited Partnership
MacroCycle uses a proprietary chemical process called SolvoGenesis, based on solvent systems and macrocyclic chemistry, to convert textile waste into pure polyester resin at low cost.
Circular EconomyCleantechNew MaterialsCambridge, US
Stwart Peña Feliz(Executive Officer, Director)inJan-Georg Rosenboom(Executive Officer, Director)
BoardCatia Cesari(Director)Temple Fennell(Director)
Co-investorsCircular Innovation FundNeotribe VenturesVolta CircleClean Energy VentureClean Energy VenturesCycle Capital
March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments.
BiotechMedical DevicesHouston, US
Sarah Hein(CEO, Co-Founder)inMaksim Mamonkin(Co-Founder, Chair Scientific Advisory Board)Malcolm Brenner(Co-founder)
BoardThomas Luby(Director)inPeter Olagunju(Director)inJoseph Petrosino(Director)
Co-investorsMission Biocapital4BIO CapitalCancer FundFitz Gate VenturesModi VenturesPortal Innovations+1 more
Marigold Health operates an anonymous online community and app where people facing mental health or substance use challenges support each other, with some members receiving one-on-one help from certified Peer Recovery Coaches.
AI & Machine LearningDigital HealthMental Health
Shrenik Jain(Founder)in
Co-investorsBantam GroupDorm RoomEpsilon Health InvestorsFlare Capital PartnersStand Together Ventures LabTamarisc Ventures+3 more
BiotechSeattle, US
Bryce R Daines(Executive Officer, Director)Max C Darnell(Executive Officer, Director)
Co-investorsMadrona Venture Group
Co-investorsMadrona Venture Group
Molecule builds a blockchain-based ecosystem that connects scientists and entrepreneurs working on decentralized science projects, with a focus on AI-driven drug discovery and research funding.
AI & Machine LearningBiotechCrypto & Web3
Co-investorsFifty YearsInflection.xyzShine CapitalAME Cloud VenturesCherubic VenturesLunar Ventures
Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.
BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US
Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)
BoardJacob Robinson(Co-founder & CEO)in
Co-investorsArboretum VenturesPsyMed VenturesTMC Venture FundCapital FactoryDivergent CapitalDolby Family Ventures+2 more
Nosis develops a platform for receptor-targeted delivery of RNA therapeutics to specific cell types, addressing a key bottleneck in RNA drug development.
AI & Machine LearningBiotechDeep TechMedical Devices
Seth Myers(Founder)in
Co-investorsAlleyCorpMadrona Venture GroupAlley Robotics Ventures
Onc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making.
AI & Machine LearningBiotechDigital Health
Co-investorsLifeX VenturesDigitalis Ventures
AI-powered pathology for improved patient outcomes
Boston, US
ANDREW BECK(Executive Officer, Director)inADITYA KHOSLA(Executive Officer, Director)
BoardMICHELLE DIPP(Director)STANLEY LAPIDUS(Director)JEFF LEIDEN(Director)
Co-investors8VCBIOSPRING PARTNERSFairhaven Capital PartnersGeneral CatalystNimble PartnersOrbiMed+2 more
Perceptive applies AI and robotics technology to dental practice, helping dentists increase patient capacity.
AI & Machine LearningHealthtechMedical DevicesRoboticsBoston, US
Chris Ciriello(Founder)inScott Phillips(Founder)inPhil Getto(CTO)Alex Furleigh(Chief of Staff)
Co-investorsAngel Physicians FundDIANecessary VenturesTSVCY Combinator
PHNX Materials refines industrial waste and byproduct streams into critical metals such as gallium, germanium, and silicon, along with products for the building materials and agriculture industries.
Circular EconomyCleantechNew Materials
Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer.
BiotechHealthtechLongevitySan Diego, US
Noah Davidsohn(CSO, Co-Founder)Daniel Oliver(CEO, Co-Founder)George Church(Co-Founder and SAB)Deborah Ascheim(Chief Medical Officer)
BoardDavid Zhu(Director)
Co-investorsCompanion FundConnecticut InnovationsDigitalis VenturesKendall Capital Partners
Reverb Therapeutics develops immunotherapies built on its Amplify•R platform, which modulates the body's natural immune system using targeted molecules such as IL-15-directed compounds.
BiotechHealthtech
BiotechWaltham, US
Ellen E. Sheets(Executive Officer, Director)
BoardCarl M. Berke(Director)Nancy Hong(Director)
Co-investorsBold Capital PartnersDigitalis VenturesRiverVest Venture Partners
Syenex provides cell delivery technologies and contract development services for therapeutic cell engineering, serving biopharmaceutical companies developing cell-based therapies.
BiotechDeep TechMedical DevicesEvanston, US
John D. Rosanelli(Executive Officer, Director)
Co-investorsAlleyCorpAlley Robotics Ventures
Tacit develops RNA repair technology called Splicing-Directed Repair, which uses naturally-occurring biological systems to fix genetic mutations as an alternative to conventional gene editing.
BiotechDeep TechHealthtech
Co-investorsEisai Innovation, Inc.Mitsui Global Investment
Terray Therapeutics develops small molecule drugs using its EMMI platform, which combines proprietary hardware, custom-generated datasets, and AI models for drug discovery.
AI & Machine LearningBiotechDeep Tech
Eli Berlin(Founder)in
Co-investorsDigitalis VenturesMadrona Venture Group
Theator builds an intelligence layer for surgery that turns video from minimally invasive procedures into usable data.
AI & Machine LearningDigital HealthHealthtechMedical DevicesPalo Alto, US
Dotan Asslemann(Director)Tamir Wolf(Executive Officer, Director)Dotan Asselmann(Founder)in
BoardGigi Levy Weiss(Director)in
Co-investorsBlumberg CapitalInsight PartnersNFXStageOne Ventures
Tierra Biosciences develops high-performance protein design technology, serving biotechnology and pharmaceutical industries.
Biotech
Co-investorsBeresford VenturesCreative VenturesFifty YearsFREEFLOWMaterial ImpactHumboldt+1 more
Co-investorsRaptor Group
ZymoChem develops bio-based materials using proprietary Carbon Conserving (C2) microbes that convert renewable feedstocks into high-value materials with increased yields.
BiotechCircular EconomyClimate TechNew MaterialsSan Leandro, US
Harshal Chokhawala(Founder & CEO)
Co-investorsAccelr8Breakout LabsBreakout VenturesCavallo VenturesDudley FundFreshTracks Capital+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 2
IPOs and acquisitions across the tracked portfolioAzitraNYSE: AZTRFaeth TherapeuticsNASDAQ: FTH
Portfolio news
latest coverage across their companies
Rejuvenate Bio · intelligence360.news · Jul 30, 2026
Solugen · agfundernews.com · Mar 19, 2026
Elegen · businesswire.com · Jan 27, 2026
Motif Neurotech · businesswire.com · Dec 16, 2025
Abridge · wsj.com · Jun 26, 2025
Character Bio · worldpharmaceuticals.net · Mar 26, 2025
Checkerspot · trysignalbase.com · Mar 4, 2025
Frequently asked questions
- What stage does KdT Ventures invest at?
- KdT Ventures invests at the Pre-Seed, Seed, Series A stages.
- What is KdT Ventures's typical check size?
- KdT Ventures typically writes checks of $500K – $3M.
- What sectors does KdT Ventures focus on?
- KdT Ventures focuses on AI & Machine Learning, Biotech, Climate Tech, Deep Tech, New Materials.
- Where is KdT Ventures located?
- KdT Ventures is headquartered in Austin, US.
- Does KdT Ventures lead rounds?
- KdT Ventures typically participates in rounds rather than leading them.
Media · Podcasts & interviews
featuring the teamVentures #3 w/ Phil Grayeski - Partner @ KdT Ventures | BIOS
BIOS · Phil Grayeski
Building Relationships in Pharma 😊 w/ Cain McClary - Founder & Managing Partner @ KdT Ventures
BIOS · Cain McClary
Leaders on a Mission - Cain McClary, Founder& Managing Partner, KdT Ventures, Episode 35
Leaders on a Mission · Cain McClary
Images
Co-investors · 7
Madrona Venture Group is a Seattle-founded venture firm that partners with founders across early and acceleration stages, providing capital plus hands-on support in recruiting, strategy, business development, and fundraising.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
Builders VC is a venture firm run by operators and investors that backs founders solving complex, mission-critical problems in industries dominated by legacy systems.
Lifeforce Capital is a venture firm investing in software companies transforming large healthcare markets.
Mayfield is a venture capital firm that invests in early-stage consumer and marketplace companies, backing founders from inception through IPO.
Industry Ventures is an investment firm founded in 2000 that provides flexible capital solutions across the venture life cycle, from seed and early-stage investing to late-stage secondaries and tech buyouts of VC-backed companies.
Firms observed investing alongside KdT Ventures, from public investor directories. Shared companies are the overlap with KdT Ventures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Overwater Ventures is an early-stage venture firm that partners with pre-seed and seed stage founders working on large-scale problems, offering hands-on support across launch strategy, go-to-market, fundraising, and marketing.
Vertex Ventures China (Vertex China) is the China-focused early-stage venture arm of Vertex Ventures, backed by Singapore's Temasek Holdings, investing in high-growth innovative technology and biomedical companies in China.
IDL Ventures is a venture capital firm and internationalization platform focused on early-stage deep technology companies primarily from emerging countries seeking to scale in the United States. The firm partners with Ignition Capital (NY) and supports startups addressing global challenges including climate change, health crises, and food scarcity.